Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt/mTOR pathway and inducing YAP translocation

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.2133226742998
   PubMed Web of Science ®Google Scholar
• Baumgartner M, Sillman AL, Blackwood EM, et al. The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors. Proc Natl Acad Sci USA. 2006;103(36):13391–13396. doi:10.1073/pnas.060595010316938849
   PubMedGoogle Scholar
• Chiasson-MacKenzie C, Morris ZS, Liu CH, Bradford WB, Koorman T, McClatchey AI. Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane: cytoskeletoninterface. Genes Dev. 2018;32(17–18):1201–1214. doi:10.1101/gad.317354.11830143526
   PubMed Web of Science ®Google Scholar
• Celik H, Bulut G, Han J, et al. Ezrin inhibition up-regulates stress response gene expression. J Biol Chem. 2016;291(25):13257–13270. doi:10.1074/jbc.M116.71818927137931
   PubMed Web of Science ®Google Scholar
• Bartova M, Hlavaty J, Tan Y, et al. Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases. Clin Exp Metastasis. 2017;34(5):333–344. doi:10.1007/s10585-017-9853-y28624994
   PubMed Web of Science ®Google Scholar
• Kobel M, Gradhand E, Zeng K, et al. Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int J Gynecol Pathol. 2006;25(2):121–130. doi:10.1097/01.pgp.0000185410.39050.ac16633060
   PubMed Web of Science ®Google Scholar
• Piao J, Liu S, Xu Y, et al. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Exp Mol Pathol. 2015;98(1):1–6. doi:10.1016/j.yexmp.2014.11.00325445504
   PubMed Web of Science ®Google Scholar
• Arpin M, Chirivino D, Naba A, Zwaenepoel I. Emerging role for ERM proteins in cell adhesion and migration. Cell Adh Migr. 2011;5(2):199–206. doi:10.4161/cam.5.2.1508121343695
   PubMed Web of Science ®Google Scholar
• Kong J, Di C, Piao J, et al. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition. Oncotarget. 2016;7(15):19631–19642.26933912
   PubMedGoogle Scholar
• Gautreau A, Poullet P, Louvard D, Arpin M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA. 1999;96(13):7300–7305. doi:10.1073/pnas.96.13.730010377409
   PubMed Web of Science ®Google Scholar
• Zhong ZQ, Song MM, He Y, Cheng S, Yuan HS. Knockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitro. Asian Pac J Cancer Prev. 2012;13(8):3781–3789.23098471
   PubMedGoogle Scholar
• Quan C, Yan Y, Qin Z, Lin Z, Quan T. Ezrin regulates skin fibroblast size/mechanical properties and YAP-dependent proliferation. JCell Commun Signal. 2018;12(3):549–560. doi:10.1007/s12079-017-0406-628889372
   PubMed Web of Science ®Google Scholar
• Jiang Z, Zhou C, Cheng L, et al. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions. JExp Clin Cancer Res. 2018;37(1):69. doi:10.1186/s13046-018-0740-429587800
   PubMedGoogle Scholar
• Chaffer CL, San Juan BP, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35(4):645–654. doi:10.1007/s10555-016-9648-727878502
   PubMed Web of Science ®Google Scholar
• Zhao LP, Huang L, Tian X, et al. Knockdown of ezrin suppresses the migration and angiogenesis of human umbilical vein endothelial cells in vitro. J Huazhong Univ Sci Technol Med Sci. 2016;36(2):243–248. doi:10.1007/s11596-016-1574-y27072970
   PubMedGoogle Scholar
• Xu W, Yang Z, Lu N. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr. 2015;9(4):317–324. doi:10.1080/19336918.2015.101668626241004
   PubMed Web of Science ®Google Scholar
• Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94(4):1287–1312. doi:10.1152/physrev.00005.201425287865
   PubMed Web of Science ®Google Scholar
• Ma L, Wang J, Lin J, Pan Q, Yu Y, Sun F. Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer. J Biol Chem. 2014;289(10):6921–6933. doi:10.1074/jbc.M113.52481924482231
   PubMed Web of Science ®Google Scholar
• Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepato-Gastroenterology. 2008;55(88):2016–2027.19260470
   PubMedGoogle Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.00228732212
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92–97. doi:10.1093/nar/gkt124824297251
   PubMed Web of Science ®Google Scholar
• Capello M, Cappello P, Linty FC, et al. Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. J Hematol Oncol. 2013;6:67. doi:10.1186/1756-8722-6-6724010981
   PubMed Web of Science ®Google Scholar
• Huang L, Qin Y, Zuo Q, et al. Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma. Int J Cancer. 2018;142(8):1652–1663. doi:10.1002/ijc.3119629210059
   PubMed Web of Science ®Google Scholar
• Li Y, Lin Z, Chen B, et al. Ezrin/NF-kB activation regulates epithelial- mesenchymal transition induced by EGF and promotes metastasis of colorectal cancer. Biomed Pharmacother. 2017;92:140–148. doi:10.1016/j.biopha.2017.05.05828535417
   PubMed Web of Science ®Google Scholar
• Krieg J, Hunter T. Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J Biol Chem. 1992;267(27):19258–19265.1382070
   PubMed Web of Science ®Google Scholar
• Krishnan K, Bruce B, Hewitt S, Thomas D, Khanna C, Helman LJ. Ezrin mediates growth and survival in Ewing’s sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway. Clin Exp Metastasis. 2006;23(3–4):227–236. doi:10.1007/s10585-006-9033-y17028919
   PubMed Web of Science ®Google Scholar
• Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nature Rev Cancer. 2015;15(2):73–79. doi:10.1038/nrc387625592648
   PubMed Web of Science ®Google Scholar
• Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nature Rev Cancer. 2013;13(4):246–257. doi:10.1038/nrc345823467301
   PubMed Web of Science ®Google Scholar
• Eibl G, RozengurtE. KRAS, YAP, and obesity in pancreatic cancer: a signaling network with multiple loops. Semin Cancer Bio 2019;54:50–62. doi:10.1016/j.semcancer.2017.10.007
   Google Scholar
• Liang N, Zhang C, Dill P, et al. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211(11):2249–2263. doi:10.1084/jem.2014034125288394
   PubMed Web of Science ®Google Scholar